These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21116263)

  • 21. Crosstalk between Opioid and Anti-Opioid Systems: An Overview and Its Possible Therapeutic Significance.
    Gibula-Tarlowska E; Kotlinska JH
    Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32998249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors.
    Grimwood S; Lu Y; Schmidt AW; Vanase-Frawley MA; Sawant-Basak A; Miller E; McLean S; Freeman J; Wong S; McLaughlin JP; Verhoest PR
    J Pharmacol Exp Ther; 2011 Nov; 339(2):555-66. PubMed ID: 21821697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychotomimetic effects of kappa opioid receptor agonists.
    White KL; Roth BL
    Biol Psychiatry; 2012 Nov; 72(10):797-8. PubMed ID: 23083945
    [No Abstract]   [Full Text] [Related]  

  • 24. Opioid Receptors.
    Stein C
    Annu Rev Med; 2016; 67():433-51. PubMed ID: 26332001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral Pharmacology of Novel Kappa Opioid Receptor Antagonists in Rats.
    Page S; Mavrikaki MM; Lintz T; Puttick D; Roberts E; Rosen H; Carroll FI; Carlezon WA; Chartoff EH
    Int J Neuropsychopharmacol; 2019 Nov; 22(11):735-745. PubMed ID: 31613314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
    Zhao M; Wang JY; Jia H; Tang JS
    Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mu and kappa opioid receptors of the periaqueductal gray stimulate and inhibit thermogenesis, respectively, during psychological stress in rats.
    Cristina-Silva C; Martins V; Gargaglioni LH; Bícego KC
    Pflugers Arch; 2017 Sep; 469(9):1151-1161. PubMed ID: 28374069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of opioid system in behavioral despair induced by social isolation stress in mice.
    Haj-Mirzaian A; Nikbakhsh R; Ramezanzadeh K; Rezaee M; Amini-Khoei H; Haj-Mirzaian A; Ghesmati M; Afshari K; Haddadi NS; Dehpour AR
    Biomed Pharmacother; 2019 Jan; 109():938-944. PubMed ID: 30551548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynorphin, stress, and depression.
    Knoll AT; Carlezon WA
    Brain Res; 2010 Feb; 1314():56-73. PubMed ID: 19782055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of kappa-opioid receptor activation in mediating antinociception and addiction.
    Wang YH; Sun JF; Tao YM; Chi ZQ; Liu JG
    Acta Pharmacol Sin; 2010 Sep; 31(9):1065-70. PubMed ID: 20729876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.
    Wee S; Koob GF
    Psychopharmacology (Berl); 2010 Jun; 210(2):121-35. PubMed ID: 20352414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Buprenorphine for opioid dependence.
    Milne M; Crouch BI; Caravati EM
    J Pain Palliat Care Pharmacother; 2009; 23(2):153-5. PubMed ID: 19492216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orally administered opioid antagonists reverse both mu and kappa opioid agonist delay of gastrointestinal transit in the guinea pig.
    Culpepper-Morgan JA; Holt PR; LaRoche D; Kreek MJ
    Life Sci; 1995; 56(14):1187-92. PubMed ID: 7475895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence.
    Rothman RB; Gorelick DA; Heishman SJ; Eichmiller PR; Hill BH; Norbeck J; Liberto JG
    J Subst Abuse Treat; 2000 Apr; 18(3):277-81. PubMed ID: 10742642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefits and Limits of Abuse-Deterrent Painkillers.
    Hendrikson H; Hanson K
    NCSL Legisbrief; 2016 Feb; 24(6):1-2. PubMed ID: 27032127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Participation of central kappa-opioid receptor in arrhythmogenesis.
    Lishmanov YB; Maslov LN; Ugdyzhekova DS; Smagin GN
    Life Sci; 1997; 61(3):PL33-8. PubMed ID: 9217295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kappa opioids and the modulation of pain.
    Kivell B; Prisinzano TE
    Psychopharmacology (Berl); 2010 Jun; 210(2):109-19. PubMed ID: 20372880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New delta-opioid antagonists as pharmacological probes.
    Bryant SD; Salvadori S; Cooper PS; Lazarus LH
    Trends Pharmacol Sci; 1998 Feb; 19(2):42-6. PubMed ID: 9550939
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.